123 related articles for article (PubMed ID: 378670)
1. Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.
Tschan M; Perruchoud A; Herzog H
Eur J Clin Pharmacol; 1979 Apr; 15(3):159-62. PubMed ID: 378670
[TBL] [Abstract][Full Text] [Related]
2. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
Brusasco V; Vibelli C; Chierichetti S; Ramoino R
Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
[TBL] [Abstract][Full Text] [Related]
3. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Baronti A; Grieco A; Vibelli C
Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
[TBL] [Abstract][Full Text] [Related]
4. [The bronchodilatory effect of fenoterol-HBr in comparison to the new beta2-bronchodilator (NAB 365, clenbuterol-HCl) (author's transl)].
Dorow P
Arzneimittelforschung; 1977; 27(10):2020-2. PubMed ID: 336056
[TBL] [Abstract][Full Text] [Related]
5. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
Pasotti C; Capra A; Vibelli C
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
[TBL] [Abstract][Full Text] [Related]
6. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
Baronti A; Grieco A; Vibelli C
Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
[TBL] [Abstract][Full Text] [Related]
7. [The clenbuterol treatment of patients with the chronic obstructive syndrome].
Ionescu AA; Bistriceanu G; Bogdan M; Duţu S
Pneumoftiziologia; 1995; 44(1-2):45-7. PubMed ID: 8721821
[TBL] [Abstract][Full Text] [Related]
8. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Ulmer WT; Scholz HJ; Baines A
Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction.
Brusasco V; Crimi E; Mangini S; Vibelli C
Curr Med Res Opin; 1980; 6(7):449-55. PubMed ID: 6988173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma.
Cummiskey J; Keelan P; Gray P; Cox GA
Ir Med J; 1978 Mar; 71(4):123-6. PubMed ID: 344272
[No Abstract] [Full Text] [Related]
11. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.
Kato H; Nakayama K; Takata Y; Kurihara J; Sakai T; Iwata K; Yamamoto I
Arzneimittelforschung; 1985; 35(7):1037-41. PubMed ID: 4052137
[TBL] [Abstract][Full Text] [Related]
12. Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.
Baronti A; Griceo A; Vibelli C
Eur J Clin Pharmacol; 1978 May; 13(3):171-7. PubMed ID: 352703
[No Abstract] [Full Text] [Related]
13. Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma.
Del Bono N; Quartieri F; Vibelli C
Curr Med Res Opin; 1979; 6(4):237-43. PubMed ID: 527347
[TBL] [Abstract][Full Text] [Related]
14. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
Papiris S; Galavotti V; Sturani C
Respiration; 1986; 49(2):101-8. PubMed ID: 3513269
[TBL] [Abstract][Full Text] [Related]
15. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
Jaffé G; Grimshaw JJ
Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
[TBL] [Abstract][Full Text] [Related]
16. [Clenbuterol: review of a new broncholytic agent].
Rensch H; Renovanz HD
Med Monatsschr; 1977 Oct; 31(10):457-60. PubMed ID: 337087
[No Abstract] [Full Text] [Related]
17. Effects of clenbuterol on pulmonary circulation and on oxygen delivery in chronic airflow obstruction.
Bertoli L; Graziina A; Lo Cicero S; Motelli R; Schiassi M
Eur J Respir Dis Suppl; 1986; 146():503-10. PubMed ID: 3465576
[No Abstract] [Full Text] [Related]
18. Effect of clenbuterol on peripheral airway obstruction in bronchial asthma.
Hida W; Sakurai M; Ichinose M; Shindoh C; Chonan T; Kikuchi Y; Inoue H; Takishima T
Curr Med Res Opin; 1985; 9(9):616-25. PubMed ID: 3902376
[TBL] [Abstract][Full Text] [Related]
19. [A study of the alveolar-arterial oxygen gradients and intrapulmonary shunt under the action of NAB-365, a new exogenous catecholamine of selective beta-2 action (author's transl)].
Montero Benzo R; Salas Font A
Med Clin (Barc); 1979 Jan; 72(1):24-8. PubMed ID: 372694
[TBL] [Abstract][Full Text] [Related]
20. Effect of an aerosol delivery system on bronchodilator activity.
Crimi N; Palermo F; Cacopardo B; Vancheri C; Oliveri R; Polosa R; Mistretta A
Ann Allergy; 1989 Jan; 62(1):26-9. PubMed ID: 2912322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
